Trials / Completed
CompletedNCT00394927
Adverse Event Scale in Patients With Epilepsy (aEscape) - A European Survey for Physicians With Epilepsy Patients
A Multicenter, Non-interventional Surveillance Study to Evaluate the Adverse Effects of Antiepileptic Drug Treatment in Patients With Epilepsy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- UCB Pharma · Industry
- Sex
- All
- Age
- 4 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the survey is to explore through a structured interview and patient examination the rate and distribution of neurological and systemic adverse effects related to antiepileptic treatment. Adverse effects and considerations to modify the therapy will be assessed in pediatric and adult patients with controlled as well as uncontrolled epilepsy with different seizure types
Conditions
Timeline
- Start date
- 2007-04-01
- Primary completion
- 2007-08-01
- Completion
- 2007-08-01
- First posted
- 2006-11-02
- Last updated
- 2012-07-19
Locations
53 sites across 7 countries: Austria, Czechia, Germany, Italy, Poland, Romania, Spain
Source: ClinicalTrials.gov record NCT00394927. Inclusion in this directory is not an endorsement.